Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis

Leri's pleonosteosis (LP) is an autosomal dominant rheumatic condition characterised by flexion contractures of the interphalangeal joints, limited motion of multiple joints, and short broad metacarpals, metatarsals and phalanges. Scleroderma-like skin thickening can be seen in some individuals...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2015-06, Vol.74 (6), p.1249-1256
Hauptverfasser: Banka, Siddharth, Cain, Stuart A, Carim, Sabrya, Daly, Sarah B, Urquhart, Jill E, Erdem, Günhan, Harris, Jade, Bottomley, Michelle, Donnai, Dian, Kerr, Bronwyn, Kingston, Helen, Superti-Furga, Andreas, Unger, Sheila, Ennis, Holly, Worthington, Jane, Herrick, Ariane L, Merry, Catherine L R, Yue, Wyatt W, Kielty, Cay M, Newman, William G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1256
container_issue 6
container_start_page 1249
container_title Annals of the rheumatic diseases
container_volume 74
creator Banka, Siddharth
Cain, Stuart A
Carim, Sabrya
Daly, Sarah B
Urquhart, Jill E
Erdem, Günhan
Harris, Jade
Bottomley, Michelle
Donnai, Dian
Kerr, Bronwyn
Kingston, Helen
Superti-Furga, Andreas
Unger, Sheila
Ennis, Holly
Worthington, Jane
Herrick, Ariane L
Merry, Catherine L R
Yue, Wyatt W
Kielty, Cay M
Newman, William G
description Leri's pleonosteosis (LP) is an autosomal dominant rheumatic condition characterised by flexion contractures of the interphalangeal joints, limited motion of multiple joints, and short broad metacarpals, metatarsals and phalanges. Scleroderma-like skin thickening can be seen in some individuals with LP. We undertook a study to characterise the phenotype of LP and identify its genetic basis. Whole-genome single-nucleotide polymorphism genotyping in two families with LP defined microduplications of chromosome 8q22.1 as the cause of this condition. Expression analysis of dermal fibroblasts from affected individuals showed overexpression of two genes, GDF6 and SDC2, within the duplicated region, leading to dysregulation of genes that encode proteins of the extracellular matrix and downstream players in the transforming growth factor (TGF)-β pathway. Western blot analysis revealed markedly decreased inhibitory SMAD6 levels in patients with LP. Furthermore, in a cohort of 330 systemic sclerosis cases, we show that the minor allele of a missense SDC2 variant, p.Ser71Thr, could confer protection against disease (p
doi_str_mv 10.1136/annrheumdis-2013-204309
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808694781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808694781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-a1473ce10203de25403d2dc253d55b01c35200b726dde44edd365eca60151f2e3</originalsourceid><addsrcrecordid>eNpNUU1vEzEUtBAVTQt_AXyDQ7f4a73OEaW0VIrUQ-G8cuyXxGjX3vp5K_Vv8QtxmlJx8XikeW9Gbwj5xNkl51J_tTHmPcyjD9gIxmV9lGTLN2TBlTaVafaWLBhjslFL3Z2SM8TflTLDzTtyKpRSwhi2IH_WkMNnpNMAKSYskDDgBbXUpbiDGIod6LOTLcHRagcW4YJmwHkoSLc5jXQMLic_T0NwVZUitYWaByEuOYXo0jhZxBB39ObqWlMbPb2_Wonnz5TTY_CANEQMu32pWBLFp5qjLqXoBsiHQHSyZZ9qHqjkPTnZ2gHhwwuek1_X33-ufjTru5vb1bd14xTXpbFcddIBZ4JJD6JVFYR3opW-bTeMO9kKxjad0N6DUuC91C04qxlv-VaAPCdfjntryocZsPRjQAfDYCOkGXtumNFL1Rlepd1RWg-BmGHbTzmMNj_1nPWHwvr_CusPhfXHwurkxxeTeTOCf53715D8CzjXmEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808694781</pqid></control><display><type>article</type><title>Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Banka, Siddharth ; Cain, Stuart A ; Carim, Sabrya ; Daly, Sarah B ; Urquhart, Jill E ; Erdem, Günhan ; Harris, Jade ; Bottomley, Michelle ; Donnai, Dian ; Kerr, Bronwyn ; Kingston, Helen ; Superti-Furga, Andreas ; Unger, Sheila ; Ennis, Holly ; Worthington, Jane ; Herrick, Ariane L ; Merry, Catherine L R ; Yue, Wyatt W ; Kielty, Cay M ; Newman, William G</creator><creatorcontrib>Banka, Siddharth ; Cain, Stuart A ; Carim, Sabrya ; Daly, Sarah B ; Urquhart, Jill E ; Erdem, Günhan ; Harris, Jade ; Bottomley, Michelle ; Donnai, Dian ; Kerr, Bronwyn ; Kingston, Helen ; Superti-Furga, Andreas ; Unger, Sheila ; Ennis, Holly ; Worthington, Jane ; Herrick, Ariane L ; Merry, Catherine L R ; Yue, Wyatt W ; Kielty, Cay M ; Newman, William G</creatorcontrib><description>Leri's pleonosteosis (LP) is an autosomal dominant rheumatic condition characterised by flexion contractures of the interphalangeal joints, limited motion of multiple joints, and short broad metacarpals, metatarsals and phalanges. Scleroderma-like skin thickening can be seen in some individuals with LP. We undertook a study to characterise the phenotype of LP and identify its genetic basis. Whole-genome single-nucleotide polymorphism genotyping in two families with LP defined microduplications of chromosome 8q22.1 as the cause of this condition. Expression analysis of dermal fibroblasts from affected individuals showed overexpression of two genes, GDF6 and SDC2, within the duplicated region, leading to dysregulation of genes that encode proteins of the extracellular matrix and downstream players in the transforming growth factor (TGF)-β pathway. Western blot analysis revealed markedly decreased inhibitory SMAD6 levels in patients with LP. Furthermore, in a cohort of 330 systemic sclerosis cases, we show that the minor allele of a missense SDC2 variant, p.Ser71Thr, could confer protection against disease (p&lt;1×10(-5)). Our work identifies the genetic cause of LP in these two families, demonstrates the phenotypic range of the condition, implicates dysregulation of extracellular matrix homoeostasis genes in its pathogenesis, and highlights the link between TGF-β/SMAD signalling, growth/differentiation factor 6 and syndecan-2. We propose that LP is an additional member of the growing 'TGF-β-pathies' group of musculoskeletal disorders, which includes Myhre syndrome, acromicric dysplasia, geleophysic dysplasias, Weill-Marchesani syndromes and stiff skin syndrome. Identification of a systemic sclerosis-protective SDC2 variant lays the foundation for exploration of the role of syndecan-2 in systemic sclerosis in the future.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2013-204309</identifier><identifier>PMID: 24442880</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Aged ; Child, Preschool ; Chromosomes, Human, Pair 8 - genetics ; Extracellular Matrix - metabolism ; Facies ; Female ; Fibroblasts - metabolism ; Gene Duplication ; Gene Expression Profiling ; Growth Differentiation Factor 6 - genetics ; Growth Differentiation Factor 6 - metabolism ; Hand Deformities, Congenital - genetics ; Hand Deformities, Congenital - metabolism ; Hand Deformities, Congenital - physiopathology ; Humans ; Infant ; Joint Diseases - congenital ; Joint Diseases - genetics ; Joint Diseases - metabolism ; Joint Diseases - physiopathology ; Male ; Middle Aged ; Ossification, Heterotopic - genetics ; Ossification, Heterotopic - metabolism ; Ossification, Heterotopic - physiopathology ; Phenotype ; Scleroderma, Systemic - genetics ; Signal Transduction ; Syndecan-2 - genetics ; Syndecan-2 - metabolism ; Transforming Growth Factor beta - metabolism ; Young Adult</subject><ispartof>Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1249-1256</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-a1473ce10203de25403d2dc253d55b01c35200b726dde44edd365eca60151f2e3</citedby><cites>FETCH-LOGICAL-c416t-a1473ce10203de25403d2dc253d55b01c35200b726dde44edd365eca60151f2e3</cites><orcidid>0000-0002-8527-2210</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3183,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24442880$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Banka, Siddharth</creatorcontrib><creatorcontrib>Cain, Stuart A</creatorcontrib><creatorcontrib>Carim, Sabrya</creatorcontrib><creatorcontrib>Daly, Sarah B</creatorcontrib><creatorcontrib>Urquhart, Jill E</creatorcontrib><creatorcontrib>Erdem, Günhan</creatorcontrib><creatorcontrib>Harris, Jade</creatorcontrib><creatorcontrib>Bottomley, Michelle</creatorcontrib><creatorcontrib>Donnai, Dian</creatorcontrib><creatorcontrib>Kerr, Bronwyn</creatorcontrib><creatorcontrib>Kingston, Helen</creatorcontrib><creatorcontrib>Superti-Furga, Andreas</creatorcontrib><creatorcontrib>Unger, Sheila</creatorcontrib><creatorcontrib>Ennis, Holly</creatorcontrib><creatorcontrib>Worthington, Jane</creatorcontrib><creatorcontrib>Herrick, Ariane L</creatorcontrib><creatorcontrib>Merry, Catherine L R</creatorcontrib><creatorcontrib>Yue, Wyatt W</creatorcontrib><creatorcontrib>Kielty, Cay M</creatorcontrib><creatorcontrib>Newman, William G</creatorcontrib><title>Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Leri's pleonosteosis (LP) is an autosomal dominant rheumatic condition characterised by flexion contractures of the interphalangeal joints, limited motion of multiple joints, and short broad metacarpals, metatarsals and phalanges. Scleroderma-like skin thickening can be seen in some individuals with LP. We undertook a study to characterise the phenotype of LP and identify its genetic basis. Whole-genome single-nucleotide polymorphism genotyping in two families with LP defined microduplications of chromosome 8q22.1 as the cause of this condition. Expression analysis of dermal fibroblasts from affected individuals showed overexpression of two genes, GDF6 and SDC2, within the duplicated region, leading to dysregulation of genes that encode proteins of the extracellular matrix and downstream players in the transforming growth factor (TGF)-β pathway. Western blot analysis revealed markedly decreased inhibitory SMAD6 levels in patients with LP. Furthermore, in a cohort of 330 systemic sclerosis cases, we show that the minor allele of a missense SDC2 variant, p.Ser71Thr, could confer protection against disease (p&lt;1×10(-5)). Our work identifies the genetic cause of LP in these two families, demonstrates the phenotypic range of the condition, implicates dysregulation of extracellular matrix homoeostasis genes in its pathogenesis, and highlights the link between TGF-β/SMAD signalling, growth/differentiation factor 6 and syndecan-2. We propose that LP is an additional member of the growing 'TGF-β-pathies' group of musculoskeletal disorders, which includes Myhre syndrome, acromicric dysplasia, geleophysic dysplasias, Weill-Marchesani syndromes and stiff skin syndrome. Identification of a systemic sclerosis-protective SDC2 variant lays the foundation for exploration of the role of syndecan-2 in systemic sclerosis in the future.</description><subject>Adult</subject><subject>Aged</subject><subject>Child, Preschool</subject><subject>Chromosomes, Human, Pair 8 - genetics</subject><subject>Extracellular Matrix - metabolism</subject><subject>Facies</subject><subject>Female</subject><subject>Fibroblasts - metabolism</subject><subject>Gene Duplication</subject><subject>Gene Expression Profiling</subject><subject>Growth Differentiation Factor 6 - genetics</subject><subject>Growth Differentiation Factor 6 - metabolism</subject><subject>Hand Deformities, Congenital - genetics</subject><subject>Hand Deformities, Congenital - metabolism</subject><subject>Hand Deformities, Congenital - physiopathology</subject><subject>Humans</subject><subject>Infant</subject><subject>Joint Diseases - congenital</subject><subject>Joint Diseases - genetics</subject><subject>Joint Diseases - metabolism</subject><subject>Joint Diseases - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Ossification, Heterotopic - genetics</subject><subject>Ossification, Heterotopic - metabolism</subject><subject>Ossification, Heterotopic - physiopathology</subject><subject>Phenotype</subject><subject>Scleroderma, Systemic - genetics</subject><subject>Signal Transduction</subject><subject>Syndecan-2 - genetics</subject><subject>Syndecan-2 - metabolism</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Young Adult</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNUU1vEzEUtBAVTQt_AXyDQ7f4a73OEaW0VIrUQ-G8cuyXxGjX3vp5K_Vv8QtxmlJx8XikeW9Gbwj5xNkl51J_tTHmPcyjD9gIxmV9lGTLN2TBlTaVafaWLBhjslFL3Z2SM8TflTLDzTtyKpRSwhi2IH_WkMNnpNMAKSYskDDgBbXUpbiDGIod6LOTLcHRagcW4YJmwHkoSLc5jXQMLic_T0NwVZUitYWaByEuOYXo0jhZxBB39ObqWlMbPb2_Wonnz5TTY_CANEQMu32pWBLFp5qjLqXoBsiHQHSyZZ9qHqjkPTnZ2gHhwwuek1_X33-ufjTru5vb1bd14xTXpbFcddIBZ4JJD6JVFYR3opW-bTeMO9kKxjad0N6DUuC91C04qxlv-VaAPCdfjntryocZsPRjQAfDYCOkGXtumNFL1Rlepd1RWg-BmGHbTzmMNj_1nPWHwvr_CusPhfXHwurkxxeTeTOCf53715D8CzjXmEg</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Banka, Siddharth</creator><creator>Cain, Stuart A</creator><creator>Carim, Sabrya</creator><creator>Daly, Sarah B</creator><creator>Urquhart, Jill E</creator><creator>Erdem, Günhan</creator><creator>Harris, Jade</creator><creator>Bottomley, Michelle</creator><creator>Donnai, Dian</creator><creator>Kerr, Bronwyn</creator><creator>Kingston, Helen</creator><creator>Superti-Furga, Andreas</creator><creator>Unger, Sheila</creator><creator>Ennis, Holly</creator><creator>Worthington, Jane</creator><creator>Herrick, Ariane L</creator><creator>Merry, Catherine L R</creator><creator>Yue, Wyatt W</creator><creator>Kielty, Cay M</creator><creator>Newman, William G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-8527-2210</orcidid></search><sort><creationdate>20150601</creationdate><title>Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis</title><author>Banka, Siddharth ; Cain, Stuart A ; Carim, Sabrya ; Daly, Sarah B ; Urquhart, Jill E ; Erdem, Günhan ; Harris, Jade ; Bottomley, Michelle ; Donnai, Dian ; Kerr, Bronwyn ; Kingston, Helen ; Superti-Furga, Andreas ; Unger, Sheila ; Ennis, Holly ; Worthington, Jane ; Herrick, Ariane L ; Merry, Catherine L R ; Yue, Wyatt W ; Kielty, Cay M ; Newman, William G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-a1473ce10203de25403d2dc253d55b01c35200b726dde44edd365eca60151f2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Child, Preschool</topic><topic>Chromosomes, Human, Pair 8 - genetics</topic><topic>Extracellular Matrix - metabolism</topic><topic>Facies</topic><topic>Female</topic><topic>Fibroblasts - metabolism</topic><topic>Gene Duplication</topic><topic>Gene Expression Profiling</topic><topic>Growth Differentiation Factor 6 - genetics</topic><topic>Growth Differentiation Factor 6 - metabolism</topic><topic>Hand Deformities, Congenital - genetics</topic><topic>Hand Deformities, Congenital - metabolism</topic><topic>Hand Deformities, Congenital - physiopathology</topic><topic>Humans</topic><topic>Infant</topic><topic>Joint Diseases - congenital</topic><topic>Joint Diseases - genetics</topic><topic>Joint Diseases - metabolism</topic><topic>Joint Diseases - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Ossification, Heterotopic - genetics</topic><topic>Ossification, Heterotopic - metabolism</topic><topic>Ossification, Heterotopic - physiopathology</topic><topic>Phenotype</topic><topic>Scleroderma, Systemic - genetics</topic><topic>Signal Transduction</topic><topic>Syndecan-2 - genetics</topic><topic>Syndecan-2 - metabolism</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Banka, Siddharth</creatorcontrib><creatorcontrib>Cain, Stuart A</creatorcontrib><creatorcontrib>Carim, Sabrya</creatorcontrib><creatorcontrib>Daly, Sarah B</creatorcontrib><creatorcontrib>Urquhart, Jill E</creatorcontrib><creatorcontrib>Erdem, Günhan</creatorcontrib><creatorcontrib>Harris, Jade</creatorcontrib><creatorcontrib>Bottomley, Michelle</creatorcontrib><creatorcontrib>Donnai, Dian</creatorcontrib><creatorcontrib>Kerr, Bronwyn</creatorcontrib><creatorcontrib>Kingston, Helen</creatorcontrib><creatorcontrib>Superti-Furga, Andreas</creatorcontrib><creatorcontrib>Unger, Sheila</creatorcontrib><creatorcontrib>Ennis, Holly</creatorcontrib><creatorcontrib>Worthington, Jane</creatorcontrib><creatorcontrib>Herrick, Ariane L</creatorcontrib><creatorcontrib>Merry, Catherine L R</creatorcontrib><creatorcontrib>Yue, Wyatt W</creatorcontrib><creatorcontrib>Kielty, Cay M</creatorcontrib><creatorcontrib>Newman, William G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Banka, Siddharth</au><au>Cain, Stuart A</au><au>Carim, Sabrya</au><au>Daly, Sarah B</au><au>Urquhart, Jill E</au><au>Erdem, Günhan</au><au>Harris, Jade</au><au>Bottomley, Michelle</au><au>Donnai, Dian</au><au>Kerr, Bronwyn</au><au>Kingston, Helen</au><au>Superti-Furga, Andreas</au><au>Unger, Sheila</au><au>Ennis, Holly</au><au>Worthington, Jane</au><au>Herrick, Ariane L</au><au>Merry, Catherine L R</au><au>Yue, Wyatt W</au><au>Kielty, Cay M</au><au>Newman, William G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>74</volume><issue>6</issue><spage>1249</spage><epage>1256</epage><pages>1249-1256</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><abstract>Leri's pleonosteosis (LP) is an autosomal dominant rheumatic condition characterised by flexion contractures of the interphalangeal joints, limited motion of multiple joints, and short broad metacarpals, metatarsals and phalanges. Scleroderma-like skin thickening can be seen in some individuals with LP. We undertook a study to characterise the phenotype of LP and identify its genetic basis. Whole-genome single-nucleotide polymorphism genotyping in two families with LP defined microduplications of chromosome 8q22.1 as the cause of this condition. Expression analysis of dermal fibroblasts from affected individuals showed overexpression of two genes, GDF6 and SDC2, within the duplicated region, leading to dysregulation of genes that encode proteins of the extracellular matrix and downstream players in the transforming growth factor (TGF)-β pathway. Western blot analysis revealed markedly decreased inhibitory SMAD6 levels in patients with LP. Furthermore, in a cohort of 330 systemic sclerosis cases, we show that the minor allele of a missense SDC2 variant, p.Ser71Thr, could confer protection against disease (p&lt;1×10(-5)). Our work identifies the genetic cause of LP in these two families, demonstrates the phenotypic range of the condition, implicates dysregulation of extracellular matrix homoeostasis genes in its pathogenesis, and highlights the link between TGF-β/SMAD signalling, growth/differentiation factor 6 and syndecan-2. We propose that LP is an additional member of the growing 'TGF-β-pathies' group of musculoskeletal disorders, which includes Myhre syndrome, acromicric dysplasia, geleophysic dysplasias, Weill-Marchesani syndromes and stiff skin syndrome. Identification of a systemic sclerosis-protective SDC2 variant lays the foundation for exploration of the role of syndecan-2 in systemic sclerosis in the future.</abstract><cop>England</cop><pmid>24442880</pmid><doi>10.1136/annrheumdis-2013-204309</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-8527-2210</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1249-1256
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_miscellaneous_1808694781
source MEDLINE; BMJ Journals - NESLi2
subjects Adult
Aged
Child, Preschool
Chromosomes, Human, Pair 8 - genetics
Extracellular Matrix - metabolism
Facies
Female
Fibroblasts - metabolism
Gene Duplication
Gene Expression Profiling
Growth Differentiation Factor 6 - genetics
Growth Differentiation Factor 6 - metabolism
Hand Deformities, Congenital - genetics
Hand Deformities, Congenital - metabolism
Hand Deformities, Congenital - physiopathology
Humans
Infant
Joint Diseases - congenital
Joint Diseases - genetics
Joint Diseases - metabolism
Joint Diseases - physiopathology
Male
Middle Aged
Ossification, Heterotopic - genetics
Ossification, Heterotopic - metabolism
Ossification, Heterotopic - physiopathology
Phenotype
Scleroderma, Systemic - genetics
Signal Transduction
Syndecan-2 - genetics
Syndecan-2 - metabolism
Transforming Growth Factor beta - metabolism
Young Adult
title Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A10%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leri's%20pleonosteosis,%20a%20congenital%20rheumatic%20disease,%20results%20from%20microduplication%20at%208q22.1%20encompassing%20GDF6%20and%20SDC2%20and%20provides%20insight%20into%20systemic%20sclerosis%20pathogenesis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Banka,%20Siddharth&rft.date=2015-06-01&rft.volume=74&rft.issue=6&rft.spage=1249&rft.epage=1256&rft.pages=1249-1256&rft.issn=0003-4967&rft.eissn=1468-2060&rft_id=info:doi/10.1136/annrheumdis-2013-204309&rft_dat=%3Cproquest_cross%3E1808694781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808694781&rft_id=info:pmid/24442880&rfr_iscdi=true